graves ophthalmopathy

Showing NaN - NaN of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Graves Ophthalmopathy Trial in Pisa (Sirolimus)

Not yet recruiting
  • Graves Ophthalmopathy
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology II
Nov 2, 2022

Graves Ophthalmopathy Trial in Italy (Tocilizumab 20 Mg/mL Intravenous Solution, MethylPREDNISolone Injectable Solution)

Recruiting
  • Graves Ophthalmopathy
  • Tocilizumab 20 Mg/mL Intravenous Solution
  • MethylPREDNISolone Injectable Solution
  • Milano, MI, Italy
  • +3 more
Aug 3, 2022

Sirolimus in Graves' Orbitopathy

Completed
  • Graves Ophthalmopathy
  • Pisa, PI, Italy
    Endocrinologia II
Apr 19, 2022

Genetics and Epigenetics of Graves' Orbitopathy

Completed
  • Graves Ophthalmopathy
  • No Intervention
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology I and II
Jul 22, 2020

Anti-insulin-like Growth Factor-1 Receptor Antibodies in Graves'

Completed
  • Graves Ophthalmopathy
  • +2 more
  • Serum antibodies against the IGF-1R
  • Pisa, Italy
    Endocrinology Unit I, University of Pisa
Jul 26, 2018